#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%

Patients who were given Roche’s experimental breast cancer pill directly after having surgery were 30% less likely to have invasive disease recurrence than those who were given standard of care, according to interim data presented ...